237 related articles for article (PubMed ID: 23648244)
1. [Evaluation on the effect of immunization and safety of live attenuated and inactivated hepatitis A vaccine in China].
Li H; Zhang XS; An J
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Jan; 34(1):24-7. PubMed ID: 23648244
[TBL] [Abstract][Full Text] [Related]
2. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
[TBL] [Abstract][Full Text] [Related]
3. Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after one single dose.
Zheng H; Chen Y; Wang F; Gong X; Wu Z; Miao N; Zhang X; Li H; Chen C; Hou X; Cui F; Wang H
Vaccine; 2011 Nov; 29(48):9098-103. PubMed ID: 21875638
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine].
Wang X; Meng Z; Li R
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):422-4. PubMed ID: 11798797
[TBL] [Abstract][Full Text] [Related]
6. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
[TBL] [Abstract][Full Text] [Related]
7. [Immune response to one booster dose of inactivated hepatitis A vaccine in college students].
Liao Z; Feng XW; Liu XE; Zhou YS; Wen HR; Peng SH; Zhang YX; Xu B; Zhuang H; Chen HY
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 May; 38(5):625-628. PubMed ID: 28651399
[No Abstract] [Full Text] [Related]
8. Development, production, and postmarketing surveillance of hepatitis A vaccines in China.
Cui F; Liang X; Wang F; Zheng H; Hutin YJ; Yang W
J Epidemiol; 2014; 24(3):169-77. PubMed ID: 24681843
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of antibody persistence between live attenuated and inactivated hepatitis A vaccines].
Liu HF; Zhang XJ; Zhang JL
Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):300-3. PubMed ID: 20077725
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis A immunisation in persons not previously exposed to hepatitis A.
Irving GJ; Holden J; Yang R; Pope D
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD009051. PubMed ID: 22786522
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
[TBL] [Abstract][Full Text] [Related]
12. Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine.
Zhang Z; Zhu X; Hu Y; Liang M; Sun J; Song Y; Yang Q; Ji H; Zeng G; Song L; Chen J
Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28319454
[TBL] [Abstract][Full Text] [Related]
13. [The investigation on the safety and immunogenicity of inactived hepatitis A vaccine AVAXIM].
Huang G; Wan Z; Li R
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):287-8. PubMed ID: 11860802
[TBL] [Abstract][Full Text] [Related]
14. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
15. [Study on the immunogenicity and safety of 2 kinds of inactivated hepatitis A vaccine vaccinated in 1-3 years old children].
Fu Y; Li ZL; Lao SJ; Wang M; Chen QB; Chen SJ; Li JG; Zhang Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):551-2. PubMed ID: 15231151
[No Abstract] [Full Text] [Related]
16. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program.
Zhuang FC; Qian W; Mao ZA; Gong YP; Jiang Q; Jiang LM; Chen NL; Chai SA; Mao JS
Chin Med J (Engl); 2005 Nov; 118(22):1851-6. PubMed ID: 16313838
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immune persistence among inactivated and live attenuated hepatitis a vaccines 2 years after a single dose.
Zhang X; An J; Tu A; Liang X; Cui F; Zheng H; Tang Y; Liu J; Wang X; Zhang N; Li H
Hum Vaccin Immunother; 2016 Sep; 12(9):2322-6. PubMed ID: 27494260
[TBL] [Abstract][Full Text] [Related]
18. Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines.
Wang XY; Xu Z; Yao X; Tian M; Zhou L; He L; Wen Y
Vaccine; 2004 May; 22(15-16):1941-5. PubMed ID: 15121306
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiological effects of live attenuated hepatitis A vaccine (H(2)-strain): results of A 10-year observation].
Zhuang F; Jiang Q; Gong Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):188-90. PubMed ID: 11860874
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
